ArticleThe Journal of clinical investigation2014

IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.

Maria Noé Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.